Clinical Trials List
2021-11-01 - 2026-08-02
Phase II
Recruiting3
ICD-10C43.9
Malignant melanoma of skin, unspecified
ICD-10D03.9
Melanoma in situ, unspecified
ICD-10Z51.12
Encounter for antineoplastic immunotherapy
ICD-9172.9
Malignant melanoma of skin, site unspecified
-
Trial Applicant
Syneos Health
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/04/01
Investigators and Locations
Co-Principal Investigator
- 吳佳哲 未分科
- 黃詩喻 未分科
- 陳彥豪 未分科
- 賴香蘭 未分科
- 陳彥仰 未分科
- Shau-Hsuan Li 未分科
- 常景棣 未分科
- 劉建廷 未分科
- Tai-Jan Chiu 未分科
- 郭明濬 未分科
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Mu-Hsin Chang 未分科
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
18 participants
-
Global
180 participants
